Munich based SIRION Biotech provides viral vectors on a custom basis to both academia & industry: adenovirus, lentivirus, adeno-associated virus. It also offers custom cell models for screening purposes. The interest in viral vectors is growing rapidly for applications both in gene function research and target validation, as well as in the context of gene therapy and vaccine development. In addition, the company participates in a series of development alliances for new therapies and products.
The company has been working on more than 500 single projects for more than 150 clients, half of them outside Germany in countries like Japan, Israel, Switzerland and USA. The company splits into laboratory & technology management and into sales & distribution. With its agents and collaborators there are far more than 20 professionals working for SIRION Biotech worldwide.